from the same hospital. Voucher specimen is deposited in our herbarium.
suggested by the manufacturer (Annexin V apoptosis detection kit, Santa Cruz Biotechnology) and subjected to flow cytometry using a flow cytometer (BD Biosciences).
DAPI staining
DAPI staining was used to analyze the apoptotic efficacy of DW-F5. A375 cells were grown on cover slips by placing them in 24 well plate and were treated with DW-F5 dissolved in DMSO for 24h. The cells were then washed with 1X PBS and were fixed using methanol-EDTA. The cells were stained with 1 µg mL -1 of DAPI and documented using a fluorescent microscope.
Western blot analysis
The expression and activation of survival signals such as ERK1/2, Akt, NF-кB, COX-2 and Bcl-2, were studied after pre-treating A375 cells with DW-F5 for different time intervals [0, 2, 4, 6, 8, 12, 24 & 48h respectively] . In all these cases PMA was used as an inducer [30 min treatment for NF-кB, ERK1/2 and Akt and 24h for COX-2 and Bcl-2]. Expression of molecules specific to melanoma signalling such as BRAF, Brn-2, β-catenin and MITF-M and the molecules involved in angiogenesis and metastasis including MMPs and VEGF were studied after treating the cells with DW-F5 for 12, 24 and 48h respectively.
Total protein isolated from cells after indicated treatments were subjected to Western blotting as described earlier 1 . Briefly, 60mg of whole cell protein was resolved on a 10-15% polyacrylamide gel, transferred to a PVDF membrane, incubated with the corresponding antibody and was detected by ECL (Millipore, Billerica, MA, USA).
DNA Fragmentation Assay
For assaying DNA fragmentation, cells were treated with DW-F5 for 48h, scraped into cold PBS and pelleted by centrifugation at 10,000 rpm for 2min. Pellet was dissolved in 400µl of
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lysis solution (100mM NaCl, 5 mM EDTA, 10 mM Tris-HCl pH 8.0, 0.5% SDS) containing 0.5 mg/ml proteinase-K, followed by overnight incubation at 37°C. After incubation, 100µl
of 5M NaCl was added and kept at 4°C for 12h followed by centrifugation at 13,000 rpm for 15 min. and DNA in the supernatant was extracted with 500µl of phenol: chloroform:
isoamyl alcohol solution (25:24:1) followed by chloroform: isoamyl alcohol (24:1) treatment.
DNA was precipitated with 1ml of ice-cold absolute ethanol, incubated at -70°C for 30min, centrifuged at 15,000 rpm for 5min, and air-dried. The pellet was dissolved in 20µl distilled water and incubated at 37°C for 30 min after adding 0.5µl of 10mg/ml RNase A. Equal concentrations of DNA were resolved on 2% agarose gel containing ethidium bromide. The bands were visualized under ultraviolet light and photographed using Flour S multiImager (Bio-Rad).
Clonogenic assay
Clonogenic assay was done as mentioned previously 2 . Briefly, 1×10 4 cells in six well plates were treated with DW-F5 for 72h and were replaced with fresh medium and incubated for 1 week. The clones developed were fixed in gluteraldehyde and stained using crystal violet.
The clones were counted and compared with the control. Colony containing more than four cells was counted as one clone.
Preparation of nuclear extract and EMSA: EMSA was performed to evaluate DNAbinding activity of NF-κB as described earlier 2 . In brief, 10 μg of nuclear proteins was incubated for 30 min with 32 P-end-labeled double-stranded NF-ĸB oligonucleotide (5' TTGTTACAAGGGACTTTCC GCTG GGGACTTTCC AGGGAG GCGTGG-3') at 37 o C and the DNA protein complex was resolved in 6.6% non-denaturing polyacrylamide gel, which was dried and visualized by Phosphor Imager (Personal Molecular Imager FX, BioRad).
(Promega Glomax 20/20). The relative renila luciferase activity [Rluc] , was normalized using the respective normal tissues.
In vivo studies
All in vivo experiments were approved by the Institute's animal ethical committee (IAEC).
Liposomal encapsulation of DW-F5 fraction
DW-F5 was encapsulated into the uni-lamellar liposome formulation containing phosphatidyl choline and cholesterol as per the method described earlier 4 . Briefly, 5 mg DW-F5, 45 mg phosphatidyl choline and 5.8 mg cholesterol were dissolved in 3:1 mixture of chloroform and methanol (100 ml). After dissolving completely, the solvent was removed using a vacuum rotary evaporator and the residue was suspended in sterile PBS. This solution was sonicated to ensure homogeneity and stored at 4 o C. This preparation was administered to experimental animals at a dose of 120 mg/kg body weight. The control animals were injected with empty liposome vehicle. The drug treatment was continued for a period of four weeks after which the mice were euthanized in CO 2 chamber.
Orthotopic xenograft model
The xenograft studies to evaluate the efficacy of DW-F5 against human skin cancer
[melanoma] were carried out in NOD-SCID (NOD.CB17-Prkdc scid /J) mice. Male NOD SCID mice of six to eight weeks old were used in this study and were maintained in animal research facility of our institute. In the standard cage conditions (temperature between 19-25°C, relative humidity 30-70% and illumination cycle set to 12h light and 12h dark), animals were housed in the groups of 4 mice for experiments. Autoclaved rice husk was used as bedding material and autoclaved rodent feed and water was given to animals ad libitum. 
Toxicological analysis
Animals were euthanized after the experimental period using CO 2 . Liver tissues of the sacrificed animals was collected and fixed in 4% paraformaldehyde and preserved in 30% 
Sample collection and preparation of tissue cryosections
At the termination of the experiment, all the animals were sacrificed using CO 2 . Tumour from both untreated and DW-F5 treated animals were excised, washed in ice-cold PBS and photographed. The radii of tumour in two different planes were measured using a vernier calliper and the volume was calculated as (length X width 2 )/2.
Tissue for sectioning were excised and fixed in 4% paraformaldehyde solution overnight, 
Histology and immunohistochemistry
For histopatholgical examination, the tissue sections were kept in room temperature for 1h, and subsequently passaged twice through PBS, then through distilled water for 5 min each and stained with hematoxylin for 30 min. Excess stain was washed off and the slides were dipped in differentiation solution (3 sec), tap water (10 min) and 70% Isopropyl alcohol (5 min) before counter stained with eosin solution for 1 min. The sections were kept in 100%
Isopropyl alcohol for 2 min twice, cleared in xylene and mounted in DPX mountant. Stained sections were observed under a light microscope and photographed.
Immunolocalization of specific proteins in the tissue sections was done using the Super Sensitive Polymer-HRP IHC Detection System (Biogenex, USA). The tissue sections were kept in room temperature for 1h, and subsequently passaged twice through PBS and then through distilled water for 5min each and subjected to heat-induced antigen retrieval in citrate buffer. Nonspecific antibody binding sites on tissue sections and endogenous peroxidase activity were blocked by appropriate reagents supplied with the kit. The primary antibody diluted in TBST was added to the tissue sections. After incubating for 2h at room temperature, the unbound antibody was washed off with PBS-T (Phosphate Buffered Saline with 0.1% Tween-20). The sections were then covered with secondary antibody provided in the kit and incubated for 20min at room temperature followed by rinsing it in PBS-T.
Immunostaining was visualized using diaminobenzidine chromogen, counterstained with
Mayer's hematoxylin and the sections were mounted using SuperMount ® mounting medium.
Photomicrographs were captured using a Nikon Eclipse microscope equipped with Image-Pro Plus software.
Fractionation of DW-F5
About 20mg of bioactive fraction (DW-F5) was further purified using silica gel (230-400 mesh) column (200mm×10mm). The column was eluted step wise with 5 ml of hexane, hexane: dichloromethane, methanol in various ratios. 41 fractions were collected and concentrated on a rotary evaporator. An aliquot of all the concentrated fractions were loaded on the activated silica gel TLC plates (20 cm×20 cm). The plates were developed using hexane: dichloromethane (15:85, 20:80, 30:70, 17:83) , methanol: chloroform (9:1) and methanol: chloroform: water (8:1:1). The spots were located by observing under UV light.
Fractions having same number of spots (Fr.22, 23, 24 & 25 and Fr.26, 27, 28, 29 & 30) with similar Rf values on TLC plate were pooled. The pooled fractions were numbered (Fr.5&
Fr.6) and were tested for cytotoxic activity. Among these, fraction number five (Fr.5) obtained from third step chromatography showed a single spot in TLC profile. This pure compound was subjected to various spectroscopic techniques for elucidation of the structure.
Fraction number 6, which contains a number of spots, was also subjected to spectral analyses in order to identify its composition.
Structure elucidation of bioactive compound and characterization of aliphatic fraction
The 1 H NMR (500 MHz) spectra and Response: Figure 1h is now changed to Figure 2i and 1c-1g is changed to 2c-2h. We did not get any fragmentation in the control sample, except a small smear, which appeared when we tried to make the fragments in the treated wells clearer. 
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